Literature DB >> 17900314

A semiparametric response surface model for assessing drug interaction.

Maiying Kong1, J Jack Lee.   

Abstract

When multiple drugs are administered simultaneously, investigators are often interested in assessing whether the drug combinations are synergistic, additive, or antagonistic. Existing response surface models are not adequate to capture the complex patterns of drug interactions. We propose a two-component semiparametric response surface model with a parametric function to describe the additive effect of a combination dose and a nonparametric function to capture the departure from the additive effect. The nonparametric function is estimated using the technique developed in thin plate splines, and the pointwise bootstrap confidence interval for this function is constructed. The proposed semiparametric model offers an effective way of formulating the additive effect while allowing the flexibility of modeling a departure from additivity. Example and simulations are given to illustrate that the proposed model provides an excellent estimation for different patterns of interactions between two drugs.

Mesh:

Year:  2007        PMID: 17900314      PMCID: PMC5096313          DOI: 10.1111/j.1541-0420.2007.00882.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  10 in total

1.  In vitro interactions of a new derivative of spicamycin, KRN5500, and other anticancer drugs using a three-dimensional model.

Authors:  F Kanzawa; K Nishio; K Fukuoka; T Sunami; N Saijo
Journal:  Cancer Chemother Pharmacol       Date:  1999       Impact factor: 3.333

2.  Experimental design and sample size determination for testing synergism in drug combination studies based on uniform measures.

Authors:  Ming Tan; Hong-Bin Fang; Guo-Liang Tian; Peter J Houghton
Journal:  Stat Med       Date:  2003-07-15       Impact factor: 2.373

Review 3.  A three-dimensional model to analyze drug-drug interactions.

Authors:  M N Prichard; C Shipman
Journal:  Antiviral Res       Date:  1990 Oct-Nov       Impact factor: 5.970

4.  A generalized response surface model with varying relative potency for assessing drug interaction.

Authors:  Maiying Kong; J Jack Lee
Journal:  Biometrics       Date:  2006-12       Impact factor: 2.571

5.  Interaction index and different methods for determining drug interaction in combination therapy.

Authors:  J J Lee; M Kong; G D Ayers; R Lotan
Journal:  J Biopharm Stat       Date:  2007       Impact factor: 1.051

6.  Evaluation of synergism or antagonism for the combined action of antiviral agents.

Authors:  J Sühnel
Journal:  Antiviral Res       Date:  1990-01       Impact factor: 5.970

Review 7.  What is synergy?

Authors:  M C Berenbaum
Journal:  Pharmacol Rev       Date:  1989-06       Impact factor: 25.468

Review 8.  The search for synergy: a critical review from a response surface perspective.

Authors:  W R Greco; G Bravo; J C Parsons
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

9.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Adv Enzyme Regul       Date:  1984

10.  Monotone smoothing with application to dose-response curves and the assessment of synergism.

Authors:  C Kelly; J Rice
Journal:  Biometrics       Date:  1990-12       Impact factor: 2.571

  10 in total
  12 in total

1.  Confidence Intervals of Interaction Index for Assessing Multiple Drug Interaction.

Authors:  J Jack Lee; Maiying Kong
Journal:  Stat Biopharm Res       Date:  2009-02-01       Impact factor: 1.452

2.  Real-Time Cell Migration Monitoring to Analyze Drug Synergism in the Scratch Assay Using the IncuCyte System.

Authors:  Dennis Kobelt; Wolfgang Walther; Ulrike S Stein
Journal:  Methods Mol Biol       Date:  2021

3.  Assessing interactions for fixed-dose drug combinations in tumor xenograft studies.

Authors:  Jianrong Wu; Lorraine Tracey; Andrew M Davidoff
Journal:  J Biopharm Stat       Date:  2012       Impact factor: 1.051

4.  Monotonic single-index models to assess drug interactions.

Authors:  Yubing Wan; Susmita Datta; J Jack Lee; Maiying Kong
Journal:  Stat Med       Date:  2016-11-02       Impact factor: 2.373

5.  Validation of a novel statistical model for assessing the synergy of combined-agent cancer chemoprevention.

Authors:  Junya Fujimoto; Maiying Kong; J Jack Lee; Waun Ki Hong; Reuben Lotan
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-27

6.  Assessing interactions for fixed-dose drug combinations in subcutaneous tumor xenograft studies.

Authors:  Jianrong Wu
Journal:  Pharm Stat       Date:  2013-03-07       Impact factor: 1.894

7.  Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism.

Authors:  Muhammad Kashif; Claes Andersson; Sharmineh Mansoori; Rolf Larsson; Peter Nygren; Mats G Gustafsson
Journal:  Oncotarget       Date:  2017-10-19

Review 8.  Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer.

Authors:  Xue-Qing Hu; Yang Sun; Eric Lau; Ming Zhao; Shi-Bing Su
Journal:  Curr Cancer Drug Targets       Date:  2016       Impact factor: 3.428

9.  Applying Emax model and bivariate thin plate splines to assess drug interactions.

Authors:  Maiying Kong; J Jack Lee
Journal:  Front Biosci (Elite Ed)       Date:  2010-01-01

10.  Emax model and interaction index for assessing drug interaction in combination studies.

Authors:  J Jack Lee; Heather Y Lin; Diane D Liu; Maiying Kong
Journal:  Front Biosci (Elite Ed)       Date:  2010-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.